Xcout IntelSign inSubscribe

Adagio Medical Holdings, Inc

ADGMMedical DevicesLaguna Hills, United States

Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.

Subscribe to see Adagio Medical Holdings, Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Adagio Medical Holdings, Inc at a glance

Adagio Medical Holdings, Inc is a medical devices company headquartered in Laguna Hills, United States. It is publicly listed (ADGM) with a market capitalisation of $3.5M. Xcout tracks 21 named people at Adagio Medical Holdings, Inc, including Todd Usen (Chief Executive Officer & Director).

Industry
Medical Devices
Headquarters
Laguna Hills, United States
Market cap
$3.5M
Employees
80
Ticker
ADGM

Adagio Medical Holdings, Inc leadership

  • Todd UsenChief Executive Officer & Director
  • Deborah KasterChief Financial Officer & Chief Business Officer
  • Alex BabkinChief Technical Officer
  • Nabil JubranChief Compliance Officer
  • Antwan GipsonSenior Vice President of Manufacturing & Operations
  • Marie-Claude JacquesSenior Vice President of Global Sales

15 more named people on record for Adagio Medical Holdings, Inc, with roles, board committees and tenure — see the full roster →

Adagio Medical Holdings, Inc competitors

A few of Adagio Medical Holdings, Inc's closest competitors — see the full list of competitors and alternatives →

AtriCure, Inc.ATRC · Medical - Instruments & SuppliesMason, United States
71% matchPublic

AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-use radiofrequency products. Its multifunctional pens, such as the MAX Pen, uniquely enable surgeons to evaluate cardiac arrhythmias, conduct temporary pacing, sensing, and stimulation, and perform tissue ablation with a single device. The Coolrail device facilitates the creation of longer linear ablation lines. For varying lengths of linear ablations, the CryoICE Cryoablation System is available. Furthermore, the EPi-Sense Guided Coagulation System is a single-use solution for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. AtriCure also provides systems for cardiac appendage management and soft-tissue closure. The AtriClip System is an implantable device accompanied by a disposable applier, while the LARIAT System offers a suture-based solution for soft-tissue closure, compatible with various anatomical shapes. Additionally, AtriCure offers supplementary surgical tools including Lumitip Dissectors, designed to separate tissues for optimal access, Glidepath guides for precise clamp placement, and Subtle Cannulas facilitating access for EPi-Sense catheters. A suite of reusable cardiac surgery instruments, crucial for procedures involving heart valve repair or replacement, is also available. The company distributes its offerings through a combination of independent distributors and direct sales personnel. Founded in 2000, AtriCure maintains its headquarters in Mason, Ohio.

Market cap$2.8B
Employees1,350
AtriCure, Inc. competitors & alternatives →
AngioDynamics, Inc.ANGO · Medical DevicesLatham, United States
70% matchPublic

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The company's portfolio includes advanced ablation systems like NanoKnife, designed for the precise surgical removal of soft tissues, and Solero microwave and radiofrequency systems, effective in ablating solid cancerous or benign growths. Additionally, they provide BioSentry tract sealant systems, IsoLoc Endorectal Balloons, Alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. Their endovascular therapies segment encompasses solutions for thrombus management, atherectomy procedures, core peripheral products, and the treatment of venous insufficiency. Furthermore, AngioDynamics is a key supplier of vascular access devices, such as peripherally inserted central catheters (PICCs), midline catheters, implantable ports, and dialysis catheters, along with associated accessories. These are primarily employed for short-duration systemic drug delivery, including chemotherapy and antibiotics, marketed under a robust portfolio of brand names such as BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax. The company distributes its offerings directly to a specialized clientele, including interventional radiologists, cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses, while also leveraging established distributor networks. Founded in 1988, AngioDynamics maintains its corporate headquarters in Latham, New York.

Market cap$476.1M
Employees632
AngioDynamics, Inc. competitors & alternatives →

Get Adagio Medical Holdings, Inc's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Adagio Medical Holdings, Inc — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Adagio Medical Holdings, Inc in Xcout Intel

  • 21 named people with titles, LinkedIn and board committees
  • 1 corporate event with sources — deals, leadership changes, layoffs
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →